Akoya Biosciences (AKYA)
NASDAQ:AKYA
US Market
Holding AKYA?
Track your performance easily

Akoya Biosciences (AKYA) Financial Statements

134 Followers

Akoya Biosciences Financial Overview

Akoya Biosciences's market cap is currently ―. The company's EPS TTM is $-1.227; its P/E ratio is -2.58; Akoya Biosciences is scheduled to report earnings on November 14, 2024, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 23.16M$ 18.35M$ 26.49M$ 25.21M$ 23.52M
Gross Profit$ 13.39M$ 8.38M$ 16.62M$ 15.28M$ 12.12M
EBIT$ -13.07M$ -23.39M$ -8.53M$ -10.66M$ -20.74M
EBITDA$ -11.41M$ -21.67M$ -6.42M$ -8.09M$ -18.47M
Net Income Common Stockholders$ -13.15M$ -23.48M$ -10.80M$ -12.92M$ -20.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 45.22M$ 61.58M$ 83.13M$ 78.59M$ 93.33M
Total Assets$ 143.75M$ 154.75M$ 180.37M$ 177.24M$ 188.88M
Total Debt$ 84.70M$ 85.19M$ 85.71M$ 75.07M$ 75.67M
Net Debt$ 39.47M$ 23.61M$ 2.58M$ -3.52M$ -17.66M
Total Liabilities$ 121.50M$ 122.03M$ 126.60M$ 115.27M$ 116.98M
Stockholders Equity$ 22.25M$ 32.72M$ 53.77M$ 61.97M$ 71.90M
Cash Flow-
Free Cash Flow$ -11.21M$ -21.63M$ -6.18M$ -14.59M$ -13.23M
Operating Cash Flow$ -11.04M$ -20.82M$ -5.58M$ -13.75M$ -11.80M
Investing Cash Flow$ 9.05M$ -48.82M$ -594.00K$ -832.00K$ -1.42M
Financing Cash Flow$ -2.13M$ -444.00K$ 11.08M$ -141.00K$ 46.33M
Currency in USD

Akoya Biosciences Earnings and Revenue History

Akoya Biosciences Debt to Assets

Akoya Biosciences Cash Flow

Akoya Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis